Antigen carbohydrate 125 as a prognostic biomarker in patients with stable chronic heart failure.

ABSTRACT:

Background

Carbohydrate antigen 125 (CA125) has been associated with a higher risk of mortality and readmission after an acute heart failure (HF) episode. However, the utility of CA125 in evaluating prognosis in chronic and stable HF is not yet established. The aim of this prospective study was to assess whether there is prognostic value of plasma CA125 in chronic HF population with reduced ejection fraction (HFrEF) after a long period of clinical stability.

Methods

Prospective cohort study that included consecutive patients with stable HFrEF who were followed in the outpatient HF clinic of the General University Hospital of Elche (Alicante, Spain) between July 2018 and January 2019. Stability was defined as the absence of hospital admissions due to HF symptoms or use of int

SUBMITTER: Guedes Ramallo P 

PROVIDER: S-EPMC12775155 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature